- Home
- GIX vs CATX Comparison
GIX vs CATX Comparison
Compare GIX & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$3.42
Company Overview
Basic Information| Metric | GIX | CATX |
|---|---|---|
| Founded | 2025 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.6M | 414.0M |
| IPO Year | 2026 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GIX | CATX |
|---|---|---|
| Price | $9.95 | $3.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 15.6K | ★ 2.1M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.80 | $1.96 |
| 52 Week High | $9.95 | $6.16 |
Technical Indicators
Market Signals| Indicator | GIX | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | 52.40 |
| Support Level | $9.92 | $2.88 |
| Resistance Level | N/A | $4.27 |
| Average True Range (ATR) | 0.01 | 0.22 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 91.33 | 60.23 |
Price Performance
Historical Comparison GIX
CATX
About GIX GigCapital9 Corp. Class A Ordinary Share
GigCapital9 Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.